{"disease":{"id":"polycystic-kidney-autosomal-dominant","name":"polycystic kidney autosomal dominant"},"drugs":{"marketed":[],"pipeline":[],"offLabel":[],"totalMarketed":0,"totalPipeline":0},"trials":{"data":[{"nct_id":"NCT06065852","title":"National Registry of Rare Kidney Diseases","phase":"","overall_status":"RECRUITING","enrollment_count":35000,"lead_sponsor_name":"UK Kidney Association","has_results":false},{"nct_id":"NCT02251275","title":"Long Term Safety of Immediate-release Tolvaptan in Subjects With Autosomal Dominant Polycystic Kidney Disease","phase":"PHASE3","overall_status":"COMPLETED","enrollment_count":1803,"lead_sponsor_name":"Otsuka Pharmaceutical Development & Commercialization, Inc.","has_results":true},{"nct_id":"NCT02847624","title":"Post-Marketing Surveillance Study of Tolvaptan in Patients With ADPKD","phase":"","overall_status":"COMPLETED","enrollment_count":1802,"lead_sponsor_name":"Otsuka Pharmaceutical Co., Ltd.","has_results":true},{"nct_id":"NCT03523728","title":"A Medical Research Study Designed to Determine if Venglustat Can be a Future Treatment for ADPKD Patients","phase":"PHASE2, PHASE3","overall_status":"TERMINATED","enrollment_count":478,"lead_sponsor_name":"Genzyme, a Sanofi Company","has_results":true},{"nct_id":"NCT02948179","title":"Using Preimplantation Genetic Diagnosis in Autosomal Dominant Polycystic Kidney Disease Patients: a Multicenter Clinical Trial","phase":"NA","overall_status":"COMPLETED","enrollment_count":459,"lead_sponsor_name":"Changlin Mei","has_results":false},{"nct_id":"NCT07280585","title":"STOP-PKD: SGLT2-inhibition to Improve Prognosis in Polycystic Kidney Disease","phase":"PHASE3","overall_status":"RECRUITING","enrollment_count":420,"lead_sponsor_name":"University of Cologne","has_results":false},{"nct_id":"NCT02656017","title":"Metformin as a Novel Therapy for Autosomal Dominant Polycystic Kidney Disease","phase":"PHASE2","overall_status":"COMPLETED","enrollment_count":97,"lead_sponsor_name":"Kyongtae Ty Bae, M.D., Ph.D.","has_results":true},{"nct_id":"NCT05500157","title":"Assessment of Treatment With Laparoscopic Fenestration or Aspiration Sclerotherapy for Large Symptomatic Hepatic Cysts","phase":"NA","overall_status":"UNKNOWN","enrollment_count":70,"lead_sponsor_name":"Radboud University Medical Center","has_results":false},{"nct_id":"NCT01559363","title":"A Safety, Pharmacokinetic & Dose-Escalation Study of KD019 in Subjects With Autosomal Dominant Polycystic Kidney Disease","phase":"PHASE1, PHASE2","overall_status":"COMPLETED","enrollment_count":69,"lead_sponsor_name":"Kadmon, a Sanofi Company","has_results":true},{"nct_id":"NCT05521191","title":"A Study of RGLS8429 in Patients With Autosomal Dominant Polycystic Kidney Disease","phase":"PHASE1","overall_status":"COMPLETED","enrollment_count":68,"lead_sponsor_name":"Regulus Therapeutics Inc.","has_results":false},{"nct_id":"NCT02494141","title":"Curcumin Therapy to Treat Vascular Dysfunction in Children and Young Adults With ADPKD","phase":"PHASE4","overall_status":"COMPLETED","enrollment_count":68,"lead_sponsor_name":"University of Colorado, Denver","has_results":true},{"nct_id":"NCT04363554","title":"The Kidneys Ability to Concentrate and Dilute Urine in Patients With Autosomal Dominant Polycystic Kidney Disease","phase":"NA","overall_status":"COMPLETED","enrollment_count":51,"lead_sponsor_name":"Regional Hospital Holstebro","has_results":false},{"nct_id":"NCT05510115","title":"Feasibility of Study of Empagliflozin in Patients With Autosomal Dominant Polycystic Kidney Disease","phase":"PHASE2","overall_status":"ACTIVE_NOT_RECRUITING","enrollment_count":50,"lead_sponsor_name":"University of Colorado, Denver","has_results":false},{"nct_id":"NCT04023214","title":"The Role of Endothelial Dysfunction in Adult Polycystic Kidney Disease","phase":"","overall_status":"COMPLETED","enrollment_count":40,"lead_sponsor_name":"Sheffield Teaching Hospitals NHS Foundation Trust","has_results":false},{"nct_id":"NCT03342742","title":"Daily Caloric Restriction and Intermittent Fasting in Overweight and Obese Adults With Autosomal Dominant Polycystic Kidney Disease","phase":"NA","overall_status":"COMPLETED","enrollment_count":29,"lead_sponsor_name":"University of Colorado, Denver","has_results":true},{"nct_id":"NCT04534985","title":"Time Restricted Feeding in Autosomal Dominant Polycystic Kidney Disease","phase":"NA","overall_status":"COMPLETED","enrollment_count":29,"lead_sponsor_name":"University of Colorado, Denver","has_results":false},{"nct_id":"NCT03687554","title":"Effect of Venglustat in Patients With Renal Impairment","phase":"PHASE1","overall_status":"COMPLETED","enrollment_count":24,"lead_sponsor_name":"Genzyme, a Sanofi Company","has_results":false},{"nct_id":"NCT04407481","title":"PErfusioN, OxyGen ConsUmptIon and ENergetics in ADPKD (PENGUIN)","phase":"","overall_status":"COMPLETED","enrollment_count":22,"lead_sponsor_name":"University of Colorado, Denver","has_results":false},{"nct_id":"NCT04536688","title":"A Study of RGLS4326 in Patients With Autosomal Dominant Polycystic Kidney Disease","phase":"PHASE1","overall_status":"COMPLETED","enrollment_count":19,"lead_sponsor_name":"Regulus Therapeutics Inc.","has_results":false}],"total":19},"guidelines":[],"source":"Drug Landscape verified database"}